Although REST has been identified to drive tumor growth in GBM via its transcription activity 27, its precise downstream regulatory targets and more detailed transcriptional regulatory mechanisms remain elusive and deserve to be better focused on and explored. The gene discussed is REST; the disease is glioblastoma.